Brian Cogley serves as Executive at Coeptis Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Brian Cogley has executed 1 insider transactions totaling $3.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 10, 2024 involved purchasing 5,000 shares valued at $3.4K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 10, 2024 | COEP | $3.4K | Purchase | 5,000 | $0.67 | Discretionary |
Brian Cogley currently holds 30,000 shares of Coeptis Therapeutics Holdings, Inc. (COEP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian Cogley has been a net buyer of COEP stock. They have purchased $3.4K and sold $0 worth of shares.
Brian Cogley's most recent insider trade was on Jan 10, 2024, when they purchased 5,000 shares at $0.67 per share.
Get notified when new Form 4 filings are submitted